<!DOCTYPE html>
<html>

<head>
	<link href="https://fonts.googleapis.com/css?family=Josefin+Sans&display=swap" rel="stylesheet" />	
	<link href="https://fonts.googleapis.com/css?family=Fira+Mono&display=swap" rel="stylesheet" />
	<link href="https://fonts.googleapis.com/css?family=Abril+Fatface&display=swap" rel="stylesheet" /><link href="./css/main.css" rel="stylesheet" />
	<link href="https://fonts.googleapis.com/css2?family=Fira+Mono:wght@700&display=swap" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css2?family=Fira+Mono:wght@500;700&display=swap" rel="stylesheet">

	<meta name ="viewport" content = "width=device-width, initial-scale=1">


<title>Research</title>

</head>

<style>
	footer {
	  text-align: left;
	  background-color: white;
	}

</style>


<body>
	<div class="sidebar">
	  <a class="about me" href="index.html">about</a>
	  <a class="research" href="research.html">research</a>

	</div>
	
	<div class="container_research">

		<!-- <article> -->

		<h1>research</h1>

		<p> 
			I generally focus my research on <u>health policy</u>, thinking about how regulation & the law impact new medical technologies (e.g., drugs, devices, digital health).<br> <br>Previously, I researched in <u>computational genomics</u> during early medical school and in <u>chemical physics</u> during my undergraduate years. <br><br>

			This page features my health policy research highlighted by subtopic. Alternatively, you can find a full list of my publications <a href = "publications.html">here</a>.

			<br><br>

		</p>


		<h4>Evidence standards for medical products</h4>
		<p>
			We were curious if it was possible to rely on real-world evidence to answer clinical questions in pandemics.  <br><br>To answer this, we compared results from observational studies for Covid-19 drugs to results from randomized clinical trials (the gold standard) looking at the same exact treatments. We published our findings in <i>The BMJ</i> showing that observational studies and RCTs frequently agreed in their conclusions. <br><br>
			<!-- *Note that observational studies are conducted by pulling data that already exists in patient charts, in contrast to the clinical trial approach which requires first recruiting patients, then testing a drug, and then collecting data.-->
		</p>
	

		<h5>
			Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.
		</h5>
		<p type="citation"> 
			<ul style="list-style: none;">
				<li><i>The BMJ</i>   <a href="https://www.bmj.com/content/377/bmj-2021-069400.full">[DOI]</a>  <a href="PDFs/Moneer_BMJ_2022.pdf"> [PDF]</a> <br></li>
				<li>May 2022</li>
				<li><span class = "name">Moneer O</span>, Daly G, Skydel JJ, Nyhan K, Lurie P, Ross JS, Wallach JD. <br></li>
			</ul>
		</p>

		<h5>
			Generating evidence during a pandemic: whatâ€™s reliable?
		</h5>
		<p type="citation"> 
			<ul style="list-style: none;">
				<li><i>The BMJ</i>   <a href="https://www.bmj.com/content/377/bmj.o1229">[DOI]</a>  <a href="PDFs/Wallach_BMJ_2022.pdf"> [PDF]</a> <br></li>
				<li>May 2022</li>
				<li>Wallach JD, <span class = "name">Moneer O</span>, Ross JS. <br></li>
			</ul>
		</p>

<p> <br> </p>

		<h4>Genetic testing: data privacy, innovation policy</h4>
		<p>
			Health data is governed weirdly in the United States, and consumers often have to rely on company goodwill versus solid regulation. For <i>Nature Medicine</i>, we explored risks posed by the genetic testing industry (e.g., 23andMe) and proposed solutions for how consumers may be safeguarded. <br><br>
			I have also written about innovation policy for diagnostics. In this paper, we showed how bad regulation allowed for the development of a Covid-19 testing monopoly, a phenomenon sharing parallels to the history of genetic testing. We argued aginst relying on exclusivity-creating patents to promote innovation and instead proposed a novel reimbursement model as a more effective incentive system. <br><br>
		</p>

		<h5>
			Direct-to-consumer personal genomic tests need better regulation.
		</h5>
		<p type="citation"> 
		<ul style="list-style: none;">	
			<li><i>Nature Medicine</i>   <a href = "https://doi.org/10.1038/s41591-021-01368-9"> [DOI]</a> <a href="PDFs/Moneer_Nature-Med_2021.pdf">[PDF]</a> <br></li>
			<li>June 2021</li>
			<li><span class = "name">Moneer O</span>, Miller JE, Shah ND, Ross JS. <br></li>
		</ul>
		</p>
 		
 		<h5>
			Covid-19, single-sourced diagnostic tests, and innovation policy. 
		</h5>
		<p type="citation">
			<ul style="list-style: none;">	
				<li><i>Journal of Law and Biosciences</i> <a href= "https://doi.org/10.1093/jlb/lsaa053">[DOI]</a> <a href="PDFs/Deb-Moneer_JLB_2020.pdf">[PDF]</a> <br></li>
				<li>July 2020</li>
				<li>*<span class = "name">Moneer O</span>, *Deb C, Price WN 2nd. <br></li>
				<li><i>*denotes equal author contributions</i></li>
			</ul>
		</p>


<p> <br></p>

		<h4>Postmarket regulation of medical products</h4>
		<p>
			This series of work evaluated the performance of FDA postmarket studies. These studies happen after a drug is already on the market and are increasingly important nowadays, as new drugs undergo less testing before approval.
			<br> <br>We found that postmarket studies can lead to worthwhile outcomes, but often are delayed and not completed on time. We proposed increasing the FDA's authority to enforce evidence generation after drug approval. <br><br>
		</p>

		<h5>
			New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence.
		</h5>
		<p type="citation"> 
			<ul style="list-style: none;">
				<li><i>Drug Safety</i>   <a href="https://doi.org/10.1007/s40264-022-01152-9">[DOI]</a>  <a href="PDFs/Moneer_DrugSafety_2022.pdf"> [PDF]</a> <br></li>
				<li>February 2022</li>
				<li><span class = "name">Moneer O</span>, Brown BL, Avorn J, Darrow JJ, Mitra-Majumdar M, Joyce KW, Ross M, Pham C, Kesselheim AS. <br></li>
			</ul>
		</p>

		<h5>
			Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020.
		</h5>
		<p type="citation"> 
		<ul style="list-style: none;">	
			<li><i>JAMA Network Open</i>  <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779381">[DOI]</a> <a href="PDFs/Moneer_JAMA-NO_2021.pdf">[PDF]</a> <br></li>
			<li> April 2021</li>
			<span class = "name">Moneer O</span>, Lee CC, Avorn J, Kesselheim AS.<br> </li>
			</ul>
		</p>

		<h5>
			Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016
		</h5>
		<p type="citation"> 
			<ul style="list-style: none;">
				<li><i>JAMA Internal Medicine</i>   <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2797103">[DOI]</a>  <a href="PDFs/Brown_JAMA_IM_2022.pdf"> [PDF]</a> <br></li>
				<li>October 2022</li>
				<li>Brown BL, Mitra-Majumdar M, Darrow JJ, <span class = "name">Moneer O</span>, Pham C, Avorn J, Kesselheim AS. <br></li>
			</ul>
		</p>

		<h5>
			An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. 
		</h5>
		<p type="citation"> 
		<ul style="list-style: none;">	
			<li><i>Health Affairs</i> <a href= "https://doi.org/10.1001/jamanetworkopen.2021.8530">[DOI]</a> <a href="PDFs/Kesselheim_HA_2020.pdf">[PDF]</a>  <br></li>
			<li>January 2021 </li>
			<li>Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, <span class = "name">Moneer O</span>, Avorn J. <br></li>
		</ul>
		</p>


<p> <br><br><br></p>

<!-- 		<h4>Chemical Physics</h4>
		<p>
		</p>

		<h5> 
			Electrostatic screening of charged defects in monolayer MoS2. 
		</h5>
		<p type="citation"> 
			<ul style="list-style: none;">	
				<li><i>Journal of Physical Chemistry Letters</i> <a href ="https://doi.org/10.1021/acs.jpclett.7b00710">[DOI]</a> <a href="PDFs/Atallah-JPC-Letters_2017.pdf">[PDF]</a> <br></li>
				<li>May 2017</li> 
				<li>Atallah TL, Wang J, Bosch M, Seo D, Burke RA, <span class = "name">Moneer O</span>, Zhu J, Theibault M, Brus LE, Hone J, Zhu XY. <br></li>
			</ul>
			
		</p>
		<p> <br> </p> -->



	</div>



</body>

</html>